CLINICAL_TRIALS
trial_result
· 2026-01-30
Clinical Trial Update: Efficacy and Safety Study of Secukinumab in Chinese Participants With Non-radiographic Axial Spondyloarthritis [Phase 3]
Summary
This document reports the completion of a Phase 3 efficacy and safety study of Secukinumab in Chinese participants with non-radiographic axial spondyloarthritis…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Novartis Pharmaceuticals | Conditions: Non-radiographic Axial Spondyloarthritis | Phase 3 | Status: COMPLETED | Results posted: 2026-01-30